Ontario Research Fund's #ResearchExcellence #Award (ORF-RE) recognizes innovative partnerships driving #research excellence and technological advancements in #Ontario. Learn more about our collaborative work at https://t.co/dZVO7VHTHj #AI #clincaltrials #Depression #schizophrenia

We engaged in a #CPIM with the #FDA! We presented #NetraAI for use as an enrichment methodology in #clinicaltrialdesign!  We're pleased to have received positive feedback & align with our mission of equipping sponsors with tech to achieve more successful clinical trial outcomes.

#ClinicalTrials fail too often and explainable AI may finally fix that. This episode breaks down how NetraAI @NetraMark_AI uncovers hidden signals in patient data to help good drugs reach the market.. $AIAI.CN $AINMF: A real paradigm shift in precision medicine. #Biotech

Just interviewed @NetraMark_AI $AIAI.CN / $AINMF one of the most interesting AI companies in the clinical-trial space. We covered: • Why 60–90% of trials fail • How “personas” can save or rescue Phase 2/3 studies • Their partnership with Worldwide Clinical Trials • FDA

Excited for our new partnership with Pentara! Together, we'll launch a novel site intelligence tool to enhance #clinicaltrial #integrity through advanced #AI #anomalydetection, enhancing confidence in #efficacy outcomes & assessment of #site irregularities. https://t.co/dZVO7VIrwR

Thrilled to announce an agreement with AlgoTx to optimize the #design of future #ATX01 trials. This #partnership will leverage cutting-edge technologies to accelerate development timelines & drive #trialsuccesses to improve #CIPN #patientlives. Read more: https://t.co/dZVO7VIrwR

In a new @ZacksSmallCap CEO Chat, @NetraMark_AI $AINMF CEO George Achilleos details how the company’s AI identifies previously unrecognized subpopulations—helping pharma sponsors reduce trial risk and improve outcomes. https://t.co/wkrTGhbswZ

🧠 Upcoming CfA Webinar | Revolutionizing Depression Care with AI 📅 Friday, July 18, 2025 🕛 12:00 – 1:00 PM ET Join us for an innovation-driven webinar hosted by our Centre for Analytics, featuring @NetraMark_AI, a Toronto-based startup redefining how we diagnose and treat

Can AI help save billions in failed clinical trials? Toronto-based @NetraMark_AI (OTCQB: $AINMF) thinks so—and they have the data to back it up. Their proprietary platform, NetraAI, just outperformed ChatGPT, DeepSeek, and traditional machine learning in uncovering high-impact

See our latest #publication on @arxiv at https://t.co/YWgo7YrkhB. We explore unique strengths of different AI models, closely compare NetraAI's framework to #DeepSeek's LLM, mirroring the human #scientific process & detail how #NetraAI understands complex #patient #populations.

#JobAlert : We are seeking a #TechnicalProjectManager to join our growing team of dedicated professionals focused on implementing breakthrough #AI discoveries to transform #clinicaltrialdesign. Learn more at https://t.co/SHUcKqx9Cd. #NowHiring #Careers #ProjectManagement

Ecstatic to announce an agreement with @worldwidetrials to transform how #globaltrials are designed & executed, leveraging our #AItechnology. We aim to speed development timelines by enabling more informed protocol development, faster decision-making, & improved patient targeting

Thrilled about our #partnership with @OntarioBrain to achieve #treatmentseparation in future #MDD #clinicaltrials. This collaboration enables us to improve the understanding of #patient responses to #treatments and #clinical #decisionmaking by integrating #neuroimaging #data.

Our #NetraAI #technology is redefining #MDD #clinicaltrial #insights and enhancing #patientstratification over traditional methods for future #psychiatrictrials. See how we achieved a 51% increase in specificity 📈 and a 28% increase in #modelaccuracy🎯 at https://t.co/EDkKczL2PC